377 related articles for article (PubMed ID: 23436228)
21. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism.
Tota S; Nath C; Najmi AK; Shukla R; Hanif K
Behav Brain Res; 2012 Jun; 232(1):66-76. PubMed ID: 22460064
[TBL] [Abstract][Full Text] [Related]
23. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
[TBL] [Abstract][Full Text] [Related]
24. Diaphragm and ventilatory dysfunction during cancer cachexia.
Roberts BM; Ahn B; Smuder AJ; Al-Rajhi M; Gill LC; Beharry AW; Powers SK; Fuller DD; Ferreira LF; Judge AR
FASEB J; 2013 Jul; 27(7):2600-10. PubMed ID: 23515443
[TBL] [Abstract][Full Text] [Related]
25. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
26. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
[TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle function during the progression of cancer cachexia in the male Apc
VanderVeen BN; Hardee JP; Fix DK; Carson JA
J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966
[TBL] [Abstract][Full Text] [Related]
28. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
29. JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia.
Mulder SE; Dasgupta A; King RJ; Abrego J; Attri KS; Murthy D; Shukla SK; Singh PK
Cancer Lett; 2020 Oct; 491():70-77. PubMed ID: 32735910
[TBL] [Abstract][Full Text] [Related]
30. Impaired skeletal muscle performance in the early stage of cardiac pressure overload in rabbits: beneficial effects of angiotensin-converting enzyme inhibition.
Coirault C; Langeron O; Lambert F; Blanc FX; Lerebours G; Claude N; Riou B; Chemla D; Lecarpentier Y
J Pharmacol Exp Ther; 1999 Oct; 291(1):70-5. PubMed ID: 10490888
[TBL] [Abstract][Full Text] [Related]
31. Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats.
Tota S; Kamat PK; Saxena G; Hanif K; Najmi AK; Nath C
Behav Brain Res; 2012 Jan; 226(1):317-30. PubMed ID: 21864581
[TBL] [Abstract][Full Text] [Related]
32. Comparative molecular analysis of early and late cancer cachexia-induced muscle wasting in mouse models.
Sun R; Zhang S; Lu X; Hu W; Lou N; Zhao Y; Zhou J; Zhang X; Yang H
Oncol Rep; 2016 Dec; 36(6):3291-3302. PubMed ID: 27748895
[TBL] [Abstract][Full Text] [Related]
33. The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.
Bonetto A; Rupert JE; Barreto R; Zimmers TA
J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929469
[TBL] [Abstract][Full Text] [Related]
34. Effects of angiotensin-converting enzyme inhibitor and exercise training on exercise capacity and skeletal muscle.
Minami N; Li Y; Guo Q; Kawamura T; Mori N; Nagasaka M; Ogawa M; Ito O; Kurosawa H; Kanazawa M; Kohzuki M
J Hypertens; 2007 Jun; 25(6):1241-8. PubMed ID: 17563537
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Sanders PM; Russell ST; Tisdale MJ
Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant supplementation accelerates cachexia development by promoting tumor growth in C26 tumor-bearing mice.
Assi M; Derbré F; Lefeuvre-Orfila L; Rébillard A
Free Radic Biol Med; 2016 Feb; 91():204-14. PubMed ID: 26708754
[TBL] [Abstract][Full Text] [Related]
37. Combined treatment of carfilzomib and z-VAD-fmk inhibits skeletal proteolysis and apoptosis and ameliorates cancer cachexia.
Wang Q; Li C; Peng X; Kang Q; Deng D; Zhang L; Zheng Y; Wang C; Qiao Z; Guo D; You S; Tang H
Med Oncol; 2015 Apr; 32(4):100. PubMed ID: 25737433
[TBL] [Abstract][Full Text] [Related]
38. Aliskiren targets multiple systems to alleviate cancer cachexia.
Wang C; Guo D; Wang Q; You S; Qiao Z; Liu Y; Dai H; Tang H
Oncol Rep; 2016 Nov; 36(5):3014-3022. PubMed ID: 27667116
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism.
Cisternas F; Morales MG; Meneses C; Simon F; Brandan E; Abrigo J; Vazquez Y; Cabello-Verrugio C
Clin Sci (Lond); 2015 Mar; 128(5):307-19. PubMed ID: 25222828
[TBL] [Abstract][Full Text] [Related]
40. Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia.
Fukawa T; Yan-Jiang BC; Min-Wen JC; Jun-Hao ET; Huang D; Qian CN; Ong P; Li Z; Chen S; Mak SY; Lim WJ; Kanayama HO; Mohan RE; Wang RR; Lai JH; Chua C; Ong HS; Tan KK; Ho YS; Tan IB; Teh BT; Shyh-Chang N
Nat Med; 2016 Jun; 22(6):666-71. PubMed ID: 27135739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
